PRO B-TYPE NATRIURETIC PEPTIDE SIGNIFICANTLY PREDICTS FUTURE VASCULAR EVENTS IN PERIPHERAL ARTERIAL DISEASE PATIENTS WITH TYPE 2 DIABETES

被引:0
|
作者
Vonbank, A. [1 ]
Saely, C. [1 ]
Rein, P. [1 ]
Zanolin, D. [2 ]
Leiherer, A. [2 ]
Drexel, H. [1 ]
机构
[1] Acad Teaching Hosp Feldkirch, Med & Cardiol, Feldkirch, Austria
[2] Vivit Inst, Vasc Res, Feldkirch, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
EAS16-0131
引用
收藏
页码:E3 / E4
页数:2
相关论文
共 50 条
  • [1] Pro B-type natriuretic peptide significantly predicts future vascular events in peripheral arterial disease patients with type 2 diabetes
    Vonbank, Alexander
    Saely, Christoph
    Rein, Philipp
    Zanolin, Daniela
    Leiherer, Andreas
    Ebner, Karl-Martin
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 : S151 - S151
  • [2] Pro-B-type Natriuretic Peptide Significantly Predicts Future Vascular Events in Peripheral Arterial Disease Patients with Type 2 Diabetes
    Vonbank, Alexander
    Saely, Christoph H.
    Rein, Philipp
    Zanolin, Daniela
    Leiherer, Andreas
    Drexel, Heinz
    DIABETES, 2015, 64 : A679 - A679
  • [3] Pro B-type natriuretic peptide stongly predicts all cause and cardiovascular mortality in peripheral arterial disease patients with as well as in those without type 2 diabetes
    Zanolin, Daniela
    Rein, Philipp
    Saely, Christoph
    Vonbank, Alexander
    Lins, Christina
    Leiherer, Andreas
    Muendlein, Axel
    Schuler, Alexandra
    Ebner, Karl-Martin
    Schwerzler, Peter
    Mader, Arthur
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S127 - S127
  • [4] Pro B-type natriuretic peptide strongly predicts all cause and cardiovascular mortality in peripheral arterial disease patients with as well as in those without type 2 diabetes
    Zanolin, Daniela
    Saely, Christoph
    Vonbank, Alexander
    Lins, Christina
    Leiherer, Andreas
    Muendlein, Axel
    Ebner, Karl-Martin
    Schwerzler, Peter
    Mader, Arthur
    Heinzle, Christine
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : 166 - 167
  • [5] Pro B-type natriuretic peptide strongly predicts all cause and cardiovascular mortality in peripheral arterial disease patients with as well as in those without type 2 diabetes
    Mader, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 : 153 - 153
  • [6] Pro-B-type Natriuretic Peptide Strongly Predicts Future Vascular Events in Peripheral Arterial Disease Patients With as Well as in Those Without the Metabolic Syndrome
    Rein, Philipp
    Saely, Christoph H.
    Zanolin, Daniela
    Vonbank, Alexander
    Leiherer, Andreas
    Drexel, Heinz
    DIABETES, 2016, 65 : A114 - A115
  • [7] Pro-B-Type Natriuretic Peptide Strongly Predicts Future Cardiovascular Events in Cardiovascular Disease Patients with Type 2 Diabetes as Well as in Those Without Type 2 Diabetes
    Saely, Christoph H.
    Vonbank, Alexander
    Heinzle, Christine
    Zanolin, Daniela
    Larcher, Barbara
    Mader, Arthur
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    DIABETES, 2018, 67
  • [8] Pro-B-type natriuretic peptide strongly predicts future cardiovascular events in cardiovascular disease patients with type 2 diabetes as well as in those without type 2 diabetes
    Saely, C. H.
    Vonbank, A.
    Heinzle, C.
    Zanolin, D.
    Larcher, B.
    Mader, A.
    Ebner, K-M.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 100 - 100
  • [9] PRO-B-TYPE NATRIURETIC PEPTIDE STRONGLY PREDICTS FUTURE CARDIOVASCULAR EVENTS IN CARDIOVASCULAR DISEASE PATIENTS WITH TYPE 2 DIABETES AS WELL AS IN THOSE WITHOUT TYPE 2 DIABETES
    Saely, C. H.
    Vonbank, A.
    Heinzle, C.
    Purin, D.
    Larcher, B.
    Mader, A.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    ATHEROSCLEROSIS, 2019, 287 : E189 - E189
  • [10] Pro-B-type natriuretic peptide strongly predicts future cardiovascular events in cardiovascular disease patients with type 2 diabetes as well as in those without type 2 diabetes
    Mader, Arthur
    Saely, Christoph
    Vonbank, Alexander
    Heinzle, Christine
    Zanolin-Purin, Daniela
    Larcher, Barbara
    Leiherer, Andreas
    Muendlein, Doz Axel
    Drexel, Heinz
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 156 - 156